All Stories

  1. Substance P in heart failure: The good and the bad

    Article • International Journal of Cardiology, January 2014, Elsevier

    Dr Scott Levick

  2. Substance P acting via the neurokinin-1 receptor regulates adverse myocardial remodeling in a rat model of hypertension

    Article • International Journal of Cardiology, October 2013, Elsevier

    Dr Scott Levick

  3. Estrogen modulates the influence of cardiac inflammatory cells on function of cardiac fibroblasts

    Article • Journal of Inflammation Research, August 2013, Taylor & Francis

    Dr Joseph S Janicki, Dr Scott Levick

  4. Alpha-calcitonin gene-related peptide is protective against pressure overload-induced heart failure

    Article • Regulatory Peptides, August 2013, Elsevier

    Dr Scott Levick

  5. Could interferon-gamma be a therapeutic target for treating heart failure?

    Article • Heart Failure Reviews, April 2013, Springer Science + Business Media

    Dr Scott Levick

  6. Gender differences in non-ischemic myocardial remodeling: are they due to estrogen modulation of cardiac mast cells and/or membrane type 1 matrix metalloproteinase

    Article • Pflügers Archiv - European Journal of Physiology, February 2013, Springer Science + Business Media

    Dr Scott Levick

  7. Stem cell factor is responsible for the rapid response in mature mast cell density in the acutely stressed heart

    Article • Journal of Molecular and Cellular Cardiology, October 2012, Elsevier

    Dr Scott Levick

  8. The Convergence of Ancient Chinese Medicine With Modern Therapeutics to Prevent Cardiac Fibrosis

    Article • American Journal of Hypertension, February 2012, Oxford University Press (OUP)

    Dr Scott Levick

  9. Prevention of adverse cardiac remodeling to volume overload in female rats is the result of an estrogen-altered mast cell phenotype

    Article • AJP Heart and Circulatory Physiology, December 2011, American Physiological Society

    Dr Scott Levick

  10. Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells

    Article • Cardiovascular Research, September 2011, European Society of Cardiology

    Dr Scott Levick

  11. Tryptase/Protease-Activated Receptor 2 Interactions Induce Selective Mitogen-Activated Protein Kinase Signaling and Collagen Synthesis by Cardiac Fibroblasts

    Article • Hypertension, August 2011, Wolters Kluwer Health

    Dr Scott Levick

  12. Cardiovascular Changes During Maturation and Ageing in Male and Female Spontaneously Hypertensive Rats

    Article • Journal of Cardiovascular Pharmacology, April 2011, Wolters Kluwer Health

    Dr Scott Levick

  13. Cardiac mast cells: the centrepiece in adverse myocardial remodelling

    Article • Cardiovascular Research, August 2010, European Society of Cardiology

    Dr Scott Levick

  14. Oxidative stress-mediated cardiac mast cell degranulation

    Article • Toxicological and Environmental Chemistry, August 2010, Taylor & Francis

    Dr Scott Levick

  15. Interleukin 6 Mediates Myocardial Fibrosis, Concentric Hypertrophy, and Diastolic Dysfunction in Rats

    Article • Hypertension, August 2010, Wolters Kluwer Health

    Dr Scott Levick

  16. Sympathetic Nervous System Modulation of Inflammation and Remodeling in the Hypertensive Heart

    Article • Hypertension, February 2010, Wolters Kluwer Health

    Dr Scott Levick

  17. TNF-  inhibition attenuates adverse myocardial remodeling in a rat model of volume overload

    Article • AJP Heart and Circulatory Physiology, August 2009, American Physiological Society

    Dr Scott Levick

  18. Cardiac Mast Cells Mediate Left Ventricular Fibrosis in the Hypertensive Rat Heart

    Article • Hypertension, June 2009, Wolters Kluwer Health

    Dr Scott Levick

  19. Regulation of matrix metalloproteinases is at the heart of myocardial remodeling

    Article • AJP Heart and Circulatory Physiology, July 2008, American Physiological Society

    Dr Scott Levick

  20. Protection from adverse myocardial remodeling secondary to chronic volume overload in mast cell deficient rats

    Article • Journal of Molecular and Cellular Cardiology, July 2008, Elsevier

    Dr Scott Levick

  21. A novel technique for isolating functional mast cells from the heart

    Article • Inflammation Research, May 2008, Springer Science + Business Media

    Dr Scott Levick

  22. Response of cardiac mast cells to atrial natriuretic peptide

    Article • AJP Heart and Circulatory Physiology, March 2007, American Physiological Society

    Dr Scott Levick

  23. Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure

    Article • AJP Heart and Circulatory Physiology, March 2007, American Physiological Society

    Dr Scott Levick

  24. Arachidonic Acid Metabolism as a Potential Mediator of Cardiac Fibrosis Associated with Inflammation

    Article • The Journal of Immunology, January 2007, The American Association of Immunologists

    Dr Scott Levick

  25. Antifibrotic Activity of an Inhibitor of Group IIA Secretory Phospholipase A2 in Young Spontaneously Hypertensive Rats

    Article • The Journal of Immunology, May 2006, The American Association of Immunologists

    Dr Scott Levick

  26. Reversal of cardiac dysfunction by selective ET‐A receptor antagonism

    Article • British Journal of Pharmacology, November 2005, Wiley

    Dr Scott Levick

  27. Increased Calcium Influx Mediates Increased Cardiac Stiffness in Hyperthyroid Rats

    Article • Cell Biochemistry and Biophysics, January 2005, Springer Science + Business Media

    Dr Scott Levick